ACM
TWST icon

Asymmetry Capital Management’s Twist Bioscience TWST Stock Holding History

Asymmetry Capital Management’s Portfolio TWST Stock Details TWST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-53,344
Closed -$2.42M – 45
2020
Q2 		$2.42M Sell
53,344
-70,776
-57% -$2.54M 1.85% 20
2020
Q1 		$3.8M Buy
124,120
+69,786
+128% +$1.88M 4.15% 10
2019
Q4 		$1.14M Buy
54,334
+16,116
+42% +$377K 2.05% 24
2019
Q3 		$913K Sell
38,218
-133,685
-78% -$3.89M 1.96% 19
2019
Q2 		$4.99M Buy
171,903
+148,170
+624% +$3.92M 2.7% 14
2019
Q1 		$550K Buy
+23,733
New +$536K 0.92% 24

Other funds holding TWST

AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Asymmetry Capital Management's TWST Position: Q3 2020 in Review

Asymmetry Capital Management sold out of Twist Bioscience (TWST) in Q3 2020, closing a stake of 53,344 shares — an estimated $2.42M sold.

Asymmetry Capital Management first reported a position in TWST in Q1 2019 and held it in 6 quarters. The position peaked at $4.99M in Q2 2019. 193 funds tracked by Wall St. Rank hold TWST as of Q3 2020.

  • Asymmetry Capital Management reported no remaining Twist Bioscience position as of Q3 2020 after selling out during the quarter.
  • Asymmetry Capital Management sold 53,344 Twist Bioscience shares in Q3 2020, an estimated $2.42M.
  • Asymmetry Capital Management first reported a position in Twist Bioscience in Q1 2019 and held it in 6 quarters.
  • Asymmetry Capital Management's Twist Bioscience position peaked at $4.99M in Q2 2019.
  • 193 funds tracked by Wall St. Rank held Twist Bioscience as of Q3 2020.

Based on Asymmetry Capital Management's 13F filing for Q3 2020, filed 12 Nov 2020.